{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"Enrollment was stopped on 30 Sep 2016; no new participants received the study drug. After Part 1, those who wished to continue were un-blinded; those on placebo were discontinued."},"pointOfContact":{"email":"CTRinfo@dsi.com","organization":"Contact for Clinical Trial Information","phone":"1-908-992-6400","title":"Daiichi Sankyo"}}